BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, Precone D, Gelatti U, Asensi V, Vaccher E; HIV HCC Cooperative Italian-Spanish Group. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004;18:2285-93. [PMID: 15577541 DOI: 10.1097/00002030-200411190-00009] [Cited by in Crossref: 182] [Cited by in F6Publishing: 155] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Cengiz C, Park JS, Saraf N, Dieterich DT. HIV and Liver Diseases: Recent Clinical Advances. Clinics in Liver Disease 2005;9:647-66. [DOI: 10.1016/j.cld.2005.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Cowell A, Shenoi SV, Kyriakides TC, Friedland G, Barakat LA. Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011. J Hosp Med 2015;10:608-14. [PMID: 26130520 DOI: 10.1002/jhm.2409] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cutrell J, Bedimo R. Non-AIDS-defining cancers among HIV-infected patients. Curr HIV/AIDS Rep 2013;10:207-16. [PMID: 23743643 DOI: 10.1007/s11904-013-0166-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
4 Nguyen ML, Farrell KJ, Gunthel CJ. Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. Curr Infect Dis Rep. 2010;12:46-55. [PMID: 21308498 DOI: 10.1007/s11908-009-0075-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
5 Huang AJ, Núñez M. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression. J Int Assoc Provid AIDS Care 2015;14:360-8. [PMID: 25999329 DOI: 10.1177/2325957415586258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Cacoub P, Dabis F, Costagliola D, Almeida K, Lert F, Piroth L, Semaille C. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int. 2015;35:65-70. [PMID: 25040895 DOI: 10.1111/liv.12639] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
7 Baraboutis IG, Papastamopoulos V, Charitsis G, Lekakis LJ, Vaslamatzis MM, Skoutelis AT. First-time use of bevacizumab for aggressive, metastatic hepatocellular carcinoma in an HIV/hepatitis B virus coinfected patient: a case report: . European Journal of Gastroenterology & Hepatology 2008;20:472-3. [DOI: 10.1097/meg.0b013e3282f16411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
8 Beauchamp E, Rollet K, Walmsley S, Wong DK, Cooper C, Klein MB; Canadian Co-infection Cohort Study (CTN222). Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort. Clin Infect Dis 2013;57:1339-42. [PMID: 23899675 DOI: 10.1093/cid/cit491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010;153:452-60. [PMID: 20921544 DOI: 10.7326/0003-4819-153-7-201010050-00008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S; Swiss HIV Cohort. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008;22:2135-41. [PMID: 18832877 DOI: 10.1097/QAD.0b013e32831103ad] [Cited by in Crossref: 117] [Cited by in F6Publishing: 63] [Article Influence: 8.4] [Reference Citation Analysis]
11 Matthews GV, Dore GJ. HIV and hepatitis C coinfection. Journal of Gastroenterology and Hepatology 2008;23:1000-8. [DOI: 10.1111/j.1440-1746.2008.05489.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
12 Park JS, Saraf N, Dieterich DT. HBV plus HCV, HCV plus HIV, HBV plus HIV. Curr Gastroenterol Rep 2006;8:67-74. [DOI: 10.1007/s11894-006-0066-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Vachon M, Perumalswami P, Dieterich DT. Hepatobiliary Manifestations of Human Immunodeficiency Virus. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 1060-82. [DOI: 10.1002/9781119950509.ch41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Soriano V, Martin-Carbonero L, Vispo E, Labarga P, Barreiro P. [Human immunodeficiency virus infection and viral hepatitis]. Enferm Infecc Microbiol Clin. 2011;29:691-701. [PMID: 21978797 DOI: 10.1016/j.eimc.2011.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
15 Duclos-Vallée JC, Teicher E, Vittecoq D, Samuel D. [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV]. Med Sci (Paris) 2007;23:723-8. [PMID: 17875290 DOI: 10.1051/medsci/20072389723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Berretta M, Zanet E, Di Benedetto F, Simonelli C, Bearz A, Morra A, Bonanno S, Berretta S, Tirelli U. Unusual Presentation of Metastatic Hepatocellular Carcinoma in an HIV/HCV Coinfected Patient: Case Report and Review of the Literature. Tumori 2008;94:589-91. [DOI: 10.1177/030089160809400424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Maponga TG, Glashoff RH, Vermeulen H, Robertson B, Burmeister S, Bernon M, Omoshoro-Jones J, Ruff P, Neugut AI, Jacobson JS, Preiser W, Andersson MI. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterol. 2020;20:226. [PMID: 32660431 DOI: 10.1186/s12876-020-01372-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nagata N, Nishijima T, Niikura R, Yokoyama T, Matsushita Y, Watanabe K, Teruya K, Kikuchi Y, Akiyama J, Yanase M, Uemura N, Oka S, Gatanaga H. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study. BMC Cancer 2018;18:1066. [PMID: 30400779 DOI: 10.1186/s12885-018-4963-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
19 Maida I, Ríos MJ, Pérez-Saleme L, Ramos B, Soriano V, Pegram PS, Mura MS, Sánchez-Margalet V, Saldívar-Cornejo I, Wilkin A, Babudieri S, Núñez M. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses 2008;24:679-83. [PMID: 18462085 DOI: 10.1089/aid.2007.0240] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
20 Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study. Journal of Hepatology 2007;47:527-37. [DOI: 10.1016/j.jhep.2007.06.010] [Cited by in Crossref: 167] [Cited by in F6Publishing: 148] [Article Influence: 11.1] [Reference Citation Analysis]
21 Soriano V, Barreiro P, Nuñez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 2006;57:815-8. [PMID: 16556638 DOI: 10.1093/jac/dkl068] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
22 Ramos-Rincon JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, González-Alcaide G, de Mendoza C, Barreiro P, Gómez-Gallego F, Corral O, Soriano V. Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades. AIDS 2022;36:249-56. [PMID: 34762389 DOI: 10.1097/QAD.0000000000003105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Saud LRC, Chagas AL, Maccali C, Pinto PVA, Horvat N, Alencar RSSM, Tani CM, Abdala E, Carrilho FJ. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior? Eur J Gastroenterol Hepatol 2021;33:583-8. [PMID: 33560682 DOI: 10.1097/MEG.0000000000002057] [Reference Citation Analysis]
24 Quiles Granado AM, Laguillo Sala G, Gómez Roselló E, Remollo Friedemann S, Pedraza Gutiérrez S. [Spinal cord compression due to metastasis from a hepatocarcinoma in an human immunodeficiency virus-positive patient. A propos of a case]. Gastroenterol Hepatol 2013;36:437-8. [PMID: 23465581 DOI: 10.1016/j.gastrohep.2012.11.008] [Reference Citation Analysis]
25 Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N; Liver Cancer in HIV and ITA.LI.CA Study Groups. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. J Clin Oncol 2019;37:296-304. [PMID: 30562130 DOI: 10.1200/JCO.18.00885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
26 Fernandes SA, Tovo CV, da Silva ALM, Pinto LP, Carteri RB, Mattos AA. Relationship between phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus. World J Hepatol 2022; 14(6): 1173-1181 [DOI: 10.4254/wjh.v14.i6.1173] [Reference Citation Analysis]
27 Martín-carbonero L, Tuma P, Vispo E, Medrano J, Labarga P, González-lahoz J, Barreiro P, Soriano V. Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis: Hepatitis C therapy in coinfected cirrhotics. Journal of Viral Hepatitis 2011;18:542-8. [DOI: 10.1111/j.1365-2893.2010.01334.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
28 Altman K, Vanness E, Westergaard RP. Cutaneous manifestations of human immunodeficiency virus: a clinical update. Curr Infect Dis Rep 2015;17:464. [PMID: 25821188 DOI: 10.1007/s11908-015-0464-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
29 Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T, Gueit I, Mortier E, Costagliola D, Morlat P. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey. HIV Med. 2015;16:230-239. [PMID: 25522874 DOI: 10.1111/hiv.12204] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
30 Venkataramani M, Hutton N, Colombani P, Anders RA, Agwu AL. Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report. AIDS Patient Care STDS 2010;24:693-6. [PMID: 20969466 DOI: 10.1089/apc.2010.0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
31 Gramenzi A, Tedeschi S, Cantarini MC, Erroi V, Tumietto F, Attard L, Calza L, Foschi FG, Caraceni P, Pavoni M, Cucchetti A, Bernardi M, Viale P, Verucchi G, Trevisani F. Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. Digestive and Liver Disease 2013;45:516-22. [DOI: 10.1016/j.dld.2012.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
32 Neau D, Winnock M, Castéra L, Bail BL, Loko M, Géraut L, Dupon M, Ragnaud J, Lacoste D, Lafon M, Bioulac-sage P, Dabis F. Prevalence of and Factors Associated With Hepatic Steatosis in Patients Coinfected With Hepatitis C Virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 2007;45:168-73. [DOI: 10.1097/qai.0b013e318042e1db] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
33 Vaccher E, Serraino D, Carbone A, De Paoli P. The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care. Oncologist 2014;19:860-7. [PMID: 24969164 DOI: 10.1634/theoncologist.2014-0024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
34 Ruiz-Sancho A, Soriano V. [HIV and HCV coinfection]. Enferm Infecc Microbiol Clin 2006;24:335-45; quiz 346. [PMID: 16762261 DOI: 10.1157/13089670] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Merchante N, Merino E, López-Aldeguer J, Jover F, Delgado-Fernández M, Galindo MJ, Ortega E, Rivero A, Mínguez C, Romero-Palacios A, Padilla S, Márquez-Solero M, Amador C, Ríos-Villegas MJ, Téllez F, Portilla J, Pineda JA. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013;56:143-50. [PMID: 22955438 DOI: 10.1093/cid/cis777] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
36 Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand. Hepatology 2008;48:1062-9. [PMID: 18697216 DOI: 10.1002/hep.22462] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
37 Lewin M, Gelu-simeon M, Ostos M, Boufassa F, Sobesky R, Teicher E, Meyer L, Fontaine H, Salmon-céron D, Samuel D, Seror O, Trinchet J, Duclos-vallée J. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Radiology 2015;277:443-53. [DOI: 10.1148/radiol.2015141500] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
38 Bonnet F, Morlat P. [Cancer and HIV infection: any association?]. Rev Med Interne 2006;27:227-35. [PMID: 16337065 DOI: 10.1016/j.revmed.2005.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
39 Rosenthal E, Salmon-céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P; the Mortavic/Mortalité 2005 Study Group. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19). HIV Medicine 2009;10:282-9. [DOI: 10.1111/j.1468-1293.2008.00686.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
40 Rafael-valdivia L, Miró JM, Rimola A. Trasplante hepático en pacientes con infección por VIH. Gastroenterología y Hepatología 2010;33:660-9. [DOI: 10.1016/j.gastrohep.2010.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Kew MC. Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol 2010; 2(2): 65-73 [PMID: 21160975 DOI: 10.4254/wjh.v2.i2.65] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
42 Rivero A, Camacho Á, Pérez-camacho I, Torre-cisneros J. Darunavir en la coinfección por VIH/VHB y/o VHC. Enfermedades Infecciosas y Microbiología Clínica 2008;26:37-42. [DOI: 10.1016/s0213-005x(08)76552-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Venanzi Rullo E, Maimone MG, Fiorica F, Ceccarelli M, Guarneri C, Berretta M, Nunnari G. Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management. Front Oncol 2021;11:689789. [PMID: 34422644 DOI: 10.3389/fonc.2021.689789] [Reference Citation Analysis]
44 Guerrini GP, Berretta M, Guaraldi G, Magistri P, Esposito G, Ballarin R, Serra V, Di Sandro S, Di Benedetto F. Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience. Cancers (Basel) 2021;13:4727. [PMID: 34572954 DOI: 10.3390/cancers13184727] [Reference Citation Analysis]
45 Rockstroh JK. Management of hepatitis C/HIV coinfection. Current Opinion in Infectious Diseases 2006;19:8-13. [DOI: 10.1097/01.qco.0000200294.22661.e0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
46 Degos F, Tural C. Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why? Journal of Hepatology 2007;47:447-50. [DOI: 10.1016/j.jhep.2007.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
47 Merchante N, Rodríguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, García-Deltoro M, Rivero-Juárez A, Téllez F, Delgado-Fernández M, Ríos-Villegas MJ, García MA, Vera-Méndez FJ, Ojeda-Burgos G, López-Ruz MA, Metola L, Omar M, Alemán-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macías J, Pineda JA; GEHEP-002 Study Group. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients. AIDS 2018;32:1423-30. [PMID: 29596108 DOI: 10.1097/QAD.0000000000001809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
48 Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH, Mulenga J, Chama D, Chi BH. HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis. 2011;3:269-274. [PMID: 21887060 DOI: 10.4103/0974-777x.83534] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
49 Negri F, Missale G, Antoni AD, Porta C. Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research. Transl Oncol 2021;14:101153. [PMID: 34144349 DOI: 10.1016/j.tranon.2021.101153] [Reference Citation Analysis]
50 Esposito V, Verdina A, Manente L, Spugnini EP, Viglietti R, Parrella R, Pagliano P, Parrella G, Galati R, De Luca A, Baldi A, Montesarchio V, Chirianni A. Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts. J Cell Physiol 2013;228:640-5. [DOI: 10.1002/jcp.24173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
51 Piroth L. [HIV-HCV co-infection: where are we now?]. Gastroenterol Clin Biol 2009;33 Suppl 2:S94-6. [PMID: 19375042 DOI: 10.1016/S0399-8320(09)72446-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Zhao H, Li J, Li S, Wang Y, Zhou J, Liu L, Wang C. Comparative Analysis of Presentation and Outcome After Liver Resection of Patients With Hepatocellular Carcinoma With and Without HIV. J Acquir Immune Defic Syndr 2021;86:361-8. [PMID: 33165126 DOI: 10.1097/QAI.0000000000002561] [Reference Citation Analysis]
53 Távora LG, Hyppolito EB, Cruz JN, Portela NM, Pereira SM, Veras CM. Hepatitis B, C and HIV co-infections seroprevalence in a northeast Brazilian center. Arq Gastroenterol 2013;50:277-80. [PMID: 24474229 DOI: 10.1590/S0004-28032013000400007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Agüero F, Laguno M, Moreno A, Rimola A, Miró JM. Management of end-stage liver disease in HIV-infected patients: . Current Opinion in HIV and AIDS 2007;2:474-81. [DOI: 10.1097/coh.0b013e3282f0aadd] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
55 Lemoine M, Ingiliz P. Liver injury in HIV monoinfected patients: should we turn a blind eye to it? Clin Res Hepatol Gastroenterol 2012;36:441-7. [PMID: 23079114 DOI: 10.1016/j.clinre.2012.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
56 Gelu-Simeon M, Sobesky R, Haïm-Boukobza S, Ostos M, Teicher E, Fontaine H, Salmon-Ceron D, Meyer L, Trinchet JC, Paule B, Samuel D, Lewin M, Duclos-Vallée JC. Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies? AIDS 2014;28:1379-91. [PMID: 24785953 DOI: 10.1097/QAD.0000000000000300] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
57 Gelu-Simeon M, Lewin M, Ostos M, Bayan T, Beso Delgado M, Teicher E, Layese R, Roudot-Thoraval F, Fontaine H, Sobesky R, Salmon-Céron D, Samuel D, Seror O, Nahon P, Meyer L, Duclos-Vallée JC; ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver Int 2019;39:136-46. [PMID: 29947467 DOI: 10.1111/liv.13921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Albini L, Calabresi A, Gotti D, Ferraresi A, Festa A, Donato F, Magoni M, Castelli F, Quiros-Roldan E. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. AIDS Res Hum Retroviruses 2013;29:1097-104. [PMID: 23581483 DOI: 10.1089/aid.2012.0321] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
59 Hu J, Liu K, Luo J. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development. Cancer Treat Res 2019;177:231-50. [PMID: 30523627 DOI: 10.1007/978-3-030-03502-0_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
60 Macdonald DC, Nelson M, Bower M, Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol 2008; 14(11): 1657-1663 [PMID: 18350596 DOI: 10.3748/wjg.14.1657] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
61 Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol. 2006;44:S65-S70. [PMID: 16338021 DOI: 10.1016/j.jhep.2005.11.015] [Cited by in Crossref: 133] [Cited by in F6Publishing: 133] [Article Influence: 7.8] [Reference Citation Analysis]
62 Rivero A, Camacho A, Pérez-Camacho I, Torre-Cisneros J. [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection]. Enferm Infecc Microbiol Clin 2008;26 Suppl 17:45-8. [PMID: 20116617 DOI: 10.1016/S0213-005X(08)76620-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
63 Núñez M. Highlights from the 1st International Workshop on HIV and Hepatitis Co-infection. HIV Clin Trials 2005;6:118-25. [PMID: 15983896 DOI: 10.1310/PY4C-4AQQ-HT9Y-0U0D] [Reference Citation Analysis]
64 Maponga TG, Matteau Matsha R, Morin S, Scheibe A, Swan T, Andrieux-Meyer I, Spearman CW, Klein MB, Rockstroh JK. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. Hepatol Med Policy 2017;2:8. [PMID: 30288321 DOI: 10.1186/s41124-017-0025-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
65 Yopp AC, Subramanian M, Jain MK, Mansour JC, Schwarz RE, Balch GC, Singal AG. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. Clin Gastroenterol Hepatol 2012;10:1284-90. [PMID: 22902759 DOI: 10.1016/j.cgh.2012.08.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
66 Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol 2021;74:931-43. [PMID: 33248171 DOI: 10.1016/j.jhep.2020.11.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
67 Merchante N, Rodríguez-Fernández M, Pineda JA. Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies. Curr HIV/AIDS Rep 2020;17:6-17. [PMID: 31933273 DOI: 10.1007/s11904-019-00475-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
68 Deeken JF, Tjen-A-Looi A, Rudek MA, Okuliar C, Young M, Little RF, Dezube BJ. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis 2012;55:1228-35. [PMID: 22776851 DOI: 10.1093/cid/cis613] [Cited by in Crossref: 133] [Cited by in F6Publishing: 120] [Article Influence: 13.3] [Reference Citation Analysis]
69 Li CW, Chen BS. Investigating HIV-Human Interaction Networks to Unravel Pathogenic Mechanism for Drug Discovery: A Systems Biology Approach. Curr HIV Res 2018;16:77-95. [PMID: 29468972 DOI: 10.2174/1570162X16666180219155324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant 2015;20:276-85. [PMID: 25944240 DOI: 10.1097/MOT.0000000000000199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Hu J, Ludgate L. HIV-HBV and HIV-HCV coinfection and liver cancer development. Cancer Treat Res. 2007;133:241-252. [PMID: 17672044 DOI: 10.1007/978-0-387-46816-7_9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
72 Gupta P, Liu B, Wu JQ, Soriano V, Vispo E, Carroll AP, Goldie BJ, Cairns MJ, Saksena NK. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection. Virology. 2014;450-451:336-349. [PMID: 24503097 DOI: 10.1016/j.virol.2013.12.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
73 D'Aiello A, Rahman N, Patrik Brodin N, Dave M, Jasra S, Kaubisch A, Kabarriti R, Chuy J. Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban Population. J Gastrointest Cancer 2022. [PMID: 35534673 DOI: 10.1007/s12029-022-00833-z] [Reference Citation Analysis]
74 Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D; ANRS CO13 Hepavih study group., ANRS CO12 Cirvir study group. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012;36:214-21. [PMID: 22189509 DOI: 10.1016/j.clinre.2011.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
75 Golse N, Duarte P, Fontana A, Bündchen C, Karam V, Allard MA, Pittau G, Ciacio O, Duclos-Vallée JC, Sa Cunha A, Castaing D, Cherqui D, Adam R, Samuel D, Vibert E. Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis. HPB (Oxford) 2020;22:900-10. [PMID: 31734238 DOI: 10.1016/j.hpb.2019.10.014] [Reference Citation Analysis]
76 Perfetti V, Ricotti M, Buonaguro F, Tirelli U, Pedrazzoli P. An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors. Infect Agent Cancer 2012;7:23. [PMID: 22950644 DOI: 10.1186/1750-9378-7-23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Wang CC, Silverberg MJ, Abrams DI. Non-AIDS-Defining Malignancies in the HIV-Infected Population. Curr Infect Dis Rep 2014;16:406. [PMID: 24844467 DOI: 10.1007/s11908-014-0406-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
78 Noy A. Optimizing treatment of HIV-associated lymphoma. Blood 2019;134:1385-94. [PMID: 30992269 DOI: 10.1182/blood-2018-01-791400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
79 Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev 2020;29:71-8. [PMID: 31575557 DOI: 10.1158/1055-9965.EPI-19-0503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008;22:1399-410. [PMID: 18614862 DOI: 10.1097/QAD.0b013e3282f8b46f] [Cited by in Crossref: 123] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]
81 Núñez M, Soriano V. Risks and benefits of antiretroviral therapy in HIV–HCV co-infected patients. Journal of Hepatology 2005;42:290-2. [DOI: 10.1016/j.jhep.2004.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
82 Malfitano A, Barbaro G, Barbarini G. Ongoing change in the treatment of HIV-associated malignancies in the HAART era. Expert Rev Clin Pharmacol 2009;2:283-93. [PMID: 24410706 DOI: 10.1586/ecp.09.1] [Reference Citation Analysis]
83 Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007;21:1073-89. [PMID: 17502718 DOI: 10.1097/QAD.0b013e3281084e4d] [Cited by in Crossref: 258] [Cited by in F6Publishing: 76] [Article Influence: 17.2] [Reference Citation Analysis]
84 Kew MC. Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon 2012;12:e7876. [PMID: 23166538 DOI: 10.5812/hepatmon.7876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
85 Sulkowski M. Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness. J Hepatol 2009;50:655-8. [PMID: 19243854 DOI: 10.1016/j.jhep.2009.01.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
86 Huang SM, Cai WP, Hu FY, Lan Y, Liao BL, Chen YP, Tang XP. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China. Int J STD AIDS 2016;27:890-7. [PMID: 26384940 DOI: 10.1177/0956462415600570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
87 Pinato DJ, Dalla Pria A, Sharma R, Bower M. Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV coinfection. AIDS 2017;31:603-11. [PMID: 28121711 DOI: 10.1097/QAD.0000000000001422] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
88 Mandorfer M, Schwabl P, Steiner S, Reiberger T, Peck-Radosavljevic M. Advances in the management of HIV/HCV coinfection. Hepatol Int. 2016;10:424-435. [PMID: 26758592 DOI: 10.1007/s12072-015-9691-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
89 Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41-53. [PMID: 27785449 DOI: 10.2147/jhc.s61146] [Cited by in Crossref: 418] [Cited by in F6Publishing: 256] [Article Influence: 69.7] [Reference Citation Analysis]
90 Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS 2011;25:691-700. [PMID: 21160411 DOI: 10.1097/QAD.0b013e3283437f77] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 7.5] [Reference Citation Analysis]
91 Lim C, Goutte N, Gervais A, Vullierme M, Valla DC, Degos F, Farges O. Standardized Care Management Ensures Similar Survival Rates in HIV-Positive and HIV-Negative Patients With Hepatocellular Carcinoma. JAIDS Journal of Acquired Immune Deficiency Syndromes 2012;61:581-7. [DOI: 10.1097/qai.0b013e31826ebdc7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
92 Della Corte C, Colombo M. Surveillance for hepatocellular carcinoma. Semin Oncol. 2012;39:384-398. [PMID: 22846857 DOI: 10.1053/j.seminoncol.2012.05.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
93 McNeil R, Guirguis-Younger M, Dilley LB, Aubry TD, Turnbull J, Hwang SW. Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis. BMC Public Health 2012;12:312. [PMID: 22545586 DOI: 10.1186/1471-2458-12-312] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
94 Vibert E, Duclos-Vallée JC, Ghigna MR, Hoti E, Salloum C, Guettier C, Castaing D, Samuel D, Adam R. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology 2011;53:475-82. [PMID: 21274869 DOI: 10.1002/hep.24062] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
95 Spagnuolo V, Galli L, Salpietro S, Gianotti N, Guffanti M, Cossarini F, Bigoloni A, Cinque P, Bossolasco S, Travi G, Fumagalli L, Lazzarin A, Castagna A. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies. Int J Cancer 2012;130:2990-6. [PMID: 21796633 DOI: 10.1002/ijc.26332] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
96 Crum-cianflone NF, Burgi A. Cancers Among HIV-infected Persons. Infectious Diseases in Clinical Practice 2006;14:258-65. [DOI: 10.1097/01.idc.0000217666.51001.c2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Berretta M, Garlassi E, Cacopardo B, Cappellani A, Guaraldi G, Cocchi S, De Paoli P, Lleshi A, Izzi I, Torresin A. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist. 2011;16:1258-1269. [PMID: 21868692 DOI: 10.1634/theoncologist.2010-0400] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
98 Di Benedetto F, De Ruvo N, Berretta M, Masetti M, Montalti R, Di Sandro S, Ballarin R, Codeluppi M, Guaraldi G, Gerunda GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008;34:422-7. [PMID: 17590564 DOI: 10.1016/j.ejso.2007.05.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
99 Trevisani F, Cantarini MC, Wands JR, Bernardi M. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis. 2008;1299-1305. [PMID: 18515282 DOI: 10.1093/carcin/bgn113] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 7.5] [Reference Citation Analysis]
100 Coyne KM, Barton SE. Epidemiology of sexually transmitted infections. Expert Review of Obstetrics & Gynecology 2014;2:803-16. [DOI: 10.1586/17474108.2.6.803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010;85:303-315. [PMID: 19887087 DOI: 10.1016/j.antiviral.2009.10.021] [Cited by in Crossref: 131] [Cited by in F6Publishing: 131] [Article Influence: 10.1] [Reference Citation Analysis]
102 Hleyhel M, Hleyhel M, Bouvier AM, Belot A, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Spano JP, Costagliola D, Grabar S; Cancer Risk Group of the French Hospital Database on HIV (FHDH-ANRS CO4). Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS 2014;28:2109-18. [PMID: 25265077 DOI: 10.1097/QAD.0000000000000382] [Cited by in Crossref: 68] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
103 Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]. Med Clin (Barc) 2016;146:511.e1-511.e22. [PMID: 26971984 DOI: 10.1016/j.medcli.2016.01.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
104 Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS 2014;28:453-65. [PMID: 24401642 DOI: 10.1097/QAD.0000000000000071] [Cited by in Crossref: 153] [Cited by in F6Publishing: 75] [Article Influence: 19.1] [Reference Citation Analysis]
105 Falade-Nwulia O, Thio CL. Liver disease, HIV and aging. Sex Health 2011;8:512-20. [PMID: 22127037 DOI: 10.1071/SH10163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
106 Eman P, Chacon E, Gupta M, Berger JC, Shah MB, El Haddad HE, El-Husseini A, Dela Cruz AC, Grigorian A, Mei X, Gedaly R. Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infection. HPB (Oxford) 2019;21:1009-16. [PMID: 30765199 DOI: 10.1016/j.hpb.2019.01.001] [Reference Citation Analysis]
107 Gidding HF, Amin J, Dore GJ, Law MG. Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C. Epidemiol Infect 2011;139:1151-8. [DOI: 10.1017/s095026881000258x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
108 Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4255] [Cited by in F6Publishing: 3974] [Article Influence: 250.3] [Reference Citation Analysis]
109 Park JS, Saraf N, Dieterich DT. Antiviral therapy in the HCV-coinfected patient with HIV and/or HBV. Curr hepatitis rep 2005;4:68-74. [DOI: 10.1007/s11901-005-0017-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
110 Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15 Suppl 4:14-22. [PMID: 21115577 DOI: 10.1634/theoncologist.2010-s4-14] [Cited by in Crossref: 293] [Cited by in F6Publishing: 161] [Article Influence: 26.6] [Reference Citation Analysis]
111 Lo Re V 3rd, Kostman JR, Amorosa VK. Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis 2008;12:587-609, ix. [PMID: 18625430 DOI: 10.1016/j.cld.2008.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
112 Pinato DJ, Sharma R, Citti C, Platt H, Ventura-Cots M, Allara E, Chen TY, Dalla Pria A, Jain M, Mínguez B, Kikuchi L, Kaufman West E, Merli M, Kaplan DE, Hasson H, Marks K, Nelson M, Núñez M, Aytaman A, Bower M, Bräu N; Liver Cancer in HIV Study Group. The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma. Aliment Pharmacol Ther 2018;47:95-103. [PMID: 29034998 DOI: 10.1111/apt.14356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
113 Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103:416-422. [PMID: 20588274 DOI: 10.1038/sj.bjc.6605756] [Cited by in Crossref: 194] [Cited by in F6Publishing: 173] [Article Influence: 16.2] [Reference Citation Analysis]
114 Roland ME, Stock PG. Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep 2006;3:132-8. [PMID: 16970840 DOI: 10.1007/BF02696657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
115 Merchante N, Rodríguez-Fernández M, Figueruela B, Rodríguez-Arrondo F, Revollo B, Ibarra S, Téllez F, Merino E, Montero-Alonso M, Galindo MJ, Rivero-Juárez A, Santos IL, Delgado-Fernández M, García-Deltoro M, Vera-Méndez FJ, García MA, Aguirrebengoa K, Portu J, Ríos-Villegas MJ, Villalobos M, Alemán-Valls MR, Mínguez C, Galera C, Macías J, Pineda JA; GEHEP-002 Study Group. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients. AIDS 2020;34:1497-507. [PMID: 32675563 DOI: 10.1097/QAD.0000000000002578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Sulkowski MS. Therapy Insight: management of hepatitis C in patients coinfected with HIV. Nat Rev Gastroenterol Hepatol 2005;2:223-31. [DOI: 10.1038/ncpgasthep0170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Quiros-Roldan E, Properzi M, Amadasi S, Raffetti E, Ferraresi A, Biasi L, Focà E, Castelli F. Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study. J Med Virol 2019;91:241-8. [PMID: 30216474 DOI: 10.1002/jmv.25317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Marcon PDS, Tovo CV, Kliemann DA, Fisch P, Mattos AA. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. World J Gastroenterol 2018; 24(5): 613-622 [PMID: 29434450 DOI: 10.3748/wjg.v24.i5.613] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
119 Bonnet F, Chêne G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 2008;20:534-40. [PMID: 19106656 DOI: 10.1097/CCO.0b013e32830a5080] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
120 Hooja S, Singhal A, Bachhiwal R, Yadav R, Vyas N. Hepatitis B virus seroprevalence and its correlation with CD4 cells and liver enzymes among human immunodeficiency virus positive individuals at a tertiary care hospital in North-West India. Int J Appl Basic Med Res 2015;5:36-40. [PMID: 25664266 DOI: 10.4103/2229-516X.149235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Engels EA. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS 2009;23:875-85. [PMID: 19349851 DOI: 10.1097/QAD.0b013e328329216a] [Cited by in Crossref: 84] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
122 Matthews G. The management of HIV and hepatitis B coinfection. Curr Opin Infect Dis 2007;20:16-21. [PMID: 17197877 DOI: 10.1097/QCO.0b013e328012c5aa] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
123 Di Benedetto F, De Ruvo N, Berretta M, Masetti M, Montalti R, Di Sandro S, Quintini C, Codeluppi M, Tirelli U, Gerunda GE. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol 2006;24:e26-7. [PMID: 16682730 DOI: 10.1200/JCO.2006.06.1374] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
124 Martín-carbonero L, Sánchez-somolinos M, García-samaniego J, Núñez MJ, Valencia ME, González-lahoz J, Soriano V. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002. J Viral Hepat 2006;13:851-7. [DOI: 10.1111/j.1365-2893.2006.00778.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
125 Merchante N, Figueruela B, Rodríguez-Fernández M, Rodríguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Téllez F, García-Deltoro M, Rivero-Juárez A, Delgado-Fernández M, Ríos-Villegas MJ, Aguirrebengoa K, García MA, Portu J, Vera-Méndez FJ, Villalobos M, Mínguez C, De Los Santos I, López-Ruz MA, Omar M, Galera C, Macias J, Pineda JA; GEHEP-002 Study Group. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients. AIDS 2019;33:269-78. [PMID: 30325782 DOI: 10.1097/QAD.0000000000002065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
126 Bruyand M, Thiébaut R, Lawson-Ayayi S, Joly P, Sasco AJ, Mercié P, Pellegrin JL, Neau D, Dabis F, Morlat P, Chêne G, Bonnet F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 2009;49:1109-16. [PMID: 19705973 DOI: 10.1086/605594] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
127 Zator ZA, Chung RT. After the cure: management of HCV after achievement of SVR. Curr HIV/AIDS Rep 2013;10:428-35. [PMID: 24218111 DOI: 10.1007/s11904-013-0181-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
128 Malyshkina A, Littwitz-Salomon E, Sutter K, Ross JA, Paschen A, Windmann S, Schimmer S, Dittmer U. Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance. Cancer Immunol Immunother 2019;68:479-88. [PMID: 30635687 DOI: 10.1007/s00262-019-02300-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Dika IE, Harding JJ, Abou-Alfa GK. Hepatocellular carcinoma in patients with HIV. Curr Opin HIV AIDS. 2017;12:20-25. [PMID: 27755152 DOI: 10.1097/coh.0000000000000335] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
130 Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Villalobos M, Omar M, Rincón P, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Palacios R, Gómez-Vidal MA, Macías J, Pineda JA; Members of the HEPAVIR-Cirrhosis Study Group. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis. J Antimicrob Chemother 2018;73:2435-43. [PMID: 29982683 DOI: 10.1093/jac/dky234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
131 Mcneil R, Guirguis-younger M. Harm Reduction and Palliative Care: Is There A Role for Supervised Drug Consumption Services? J Palliat Care 2012;28:175-7. [DOI: 10.1177/082585971202800308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
132 Noy A. HIV Lymphoma and Burkitts Lymphoma. Cancer J 2020;26:260-8. [PMID: 32496459 DOI: 10.1097/PPO.0000000000000448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 García-García JA, Romero-Gómez M, Girón-González JA, Rivera-Irigoin R, Torre-Cisneros J, Montero JL, González-Serrano M, Andrade RJ, Aguilar-Guisado M, Grilo I, Martín-Vivaldi J, Salmerón J, Caballero-Granado FJ, Macías J, Vergara-López S, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas (GAEI)., Grupo Andaluz para el Estudio del Hígado (GAEH). Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. AIDS Res Hum Retroviruses 2006;22:1236-41. [PMID: 17209765 DOI: 10.1089/aid.2006.22.1236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
134 Gidding HF, Dore GJ, Amin J, Law MG. Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study. BMC Public Health 2011;11:52. [PMID: 21261993 DOI: 10.1186/1471-2458-11-52] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
135 Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377:1198-1209. [PMID: 21459211 DOI: 10.1016/s0140-6736(10)62001-6] [Cited by in Crossref: 178] [Cited by in F6Publishing: 90] [Article Influence: 16.2] [Reference Citation Analysis]
136 Streeck H, Rockstroh JK. Challenges in the treatment of HIV and HCV coinfection. Expert Review of Clinical Immunology 2014;2:811-22. [DOI: 10.1586/1744666x.2.5.811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 2013;57:1638-1647. [PMID: 23899679 DOI: 10.1093/cid/cit497] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
138 Della Corte C, Aghemo A, Colombo M. Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies. World J Gastroenterol 2013; 19(9): 1359-1371 [PMID: 23538741 DOI: 10.3748/wjg.v19.i9.1359] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
139 Soriano V. Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates. J Hepatol 2006;44:S44-8. [PMID: 16352362 DOI: 10.1016/j.jhep.2005.11.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
140 Javadi S, Menias CO, Karbasian N, Shaaban A, Shah K, Osman A, Jensen CT, Lubner MG, Gaballah AH, Elsayes KM. HIV-related Malignancies and Mimics: Imaging Findings and Management. Radiographics 2018;38:2051-68. [PMID: 30339518 DOI: 10.1148/rg.2018180149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
141 Scott JA, Chew KW. Treatment optimization for HIV/HCV co-infected patients. Ther Adv Infect Dis 2017;4:18-36. [PMID: 28357062 DOI: 10.1177/2049936116681279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
142 Kew MC, Smuts H, Stewart A. Does HIV Infection Enhance the Hepatocarcinogenic Potential of Chronic Hepatitis B Virus Infection? JAIDS Journal of Acquired Immune Deficiency Syndromes 2010;53:413-4. [DOI: 10.1097/qai.0b013e3181ba390f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Benedetto ND, Peralta M, Alvarez E, Schroder MT, Estepo C, Paz S, Fainboim H. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011. Annals of Hepatology 2014;13:38-44. [DOI: 10.1016/s1665-2681(19)30902-0] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
144 Okeke E, Mark Davwar P, Mullen B, Duguru M, Agbaji O, Sagay A, Murphy R, Hawkins C. The impact of HIV on hepatocellular cancer survival in Nigeria. Trop Med Int Health 2021;26:335-42. [PMID: 33244817 DOI: 10.1111/tmi.13532] [Reference Citation Analysis]
145 Cenderello G, Pontali E, Cassola G, Torresin A. Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports. Infection 2013;41:199-202. [PMID: 23065464 DOI: 10.1007/s15010-012-0353-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
146 Lieveld FI, Smit C, Richter C, van Erpecum KJ, Spanier BWM, Gisolf EH, Vrolijk JM, Siersema PD, Hoepelman AIM, Reiss P, Arends JE. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection. Liver Int 2019;39:470-83. [PMID: 30411848 DOI: 10.1111/liv.14000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
147 Casper C, Crane H, Menon M, Money D. HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases. The World Bank; 2017. pp. 45-66. [DOI: 10.1596/978-1-4648-0524-0_ch3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
148 Araújo-Mariz C, Lopes EP, Ximenes RA, Lacerda HR, Miranda-Filho DB, Montarroyos UR, Barreto S, Salustiano DM, Albuquerque MF. Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis. J Med Virol. 2016;88:996-1002. [PMID: 26580855 DOI: 10.1002/jmv.24432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
149 Puoti M, Nasta P, Gatti F, Matti A, Prestini K, Biasi L, Carosi G. HIV-related liver disease: ARV drugs, coinfection, and other risk factors. J Int Assoc Physicians AIDS Care (Chic) 2009;8:30-42. [PMID: 19211929 DOI: 10.1177/1545109708330906] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
150 Morsica G, Galli L, Messina E, Cibarelli A, Bagaglio S, Poli A, Ranzenigo M, Castagna A, Hasson H, Uberti-foppa C, Granito A. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/3586064] [Reference Citation Analysis]
151 Soriano V, Martin-carbonero L, Maida I, Garcia-samaniego J, Nuñez M. New paradigms in the management of HIV and hepatitis C virus coinfection: . Current Opinion in Infectious Diseases 2005;18:550-60. [DOI: 10.1097/01.qco.0000191509.56104.ec] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
152 Riedel DJ, Tang LS, Rositch AF. The role of viral co-infection in HIV-associated non-AIDS-related cancers. Curr HIV/AIDS Rep 2015;12:362-72. [PMID: 26152660 DOI: 10.1007/s11904-015-0276-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
153 Kong L, Wei G, Lv T, Jiang L, Yang J, Zhao Y, Yang J. Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma. Sci Rep 2021;11:696. [PMID: 33436856 DOI: 10.1038/s41598-020-80311-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Di Benedetto F, Tarantino G, De Ruvo N, Cautero N, Montalti R, Guerrini GP, Ballarin R, Spaggiari M, Smerieri N, Serra V, Rompianesi G, D'Amico G, Mimmo A, Iemmolo RM, Codeluppi M, Cocchi S, Guaraldi G, Gerunda GE. University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplant Proc 2011;43:1114-8. [PMID: 21620066 DOI: 10.1016/j.transproceed.2011.03.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
155 Powles T, Macdonald D, Nelson M, Stebbing J. Hepatocellular cancer in HIV-infected individuals: tomorrow’s problem? Expert Review of Anticancer Therapy 2014;6:1553-8. [DOI: 10.1586/14737140.6.11.1553] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
156 Tholey DM, Ahn J. Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2015;44:761-73. [DOI: 10.1016/j.gtc.2015.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
157 Fonquernie F, Lacombe K, Vincensini JP, Boccara F, Clozel S, Ayouch Boda A, Bollens D, Campa P, Pacanowski J, Meynard JL, Meyohas MC, Girard PM. How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program. AIDS Care 2010;22:588-96. [PMID: 20401768 DOI: 10.1080/09540120903280893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
158 Gaeta GB, Precone DF, Cozzi-lepri A, Cicconi P, Monforte AD. Multiple viral infections. Journal of Hepatology 2006;44:S108-13. [DOI: 10.1016/j.jhep.2005.11.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]